Condition: Microbiome Dysbiosis · Gut Health · Sponsor: dsm-firmenich Switzerland AG
Recent studies suggest B-vitamins such as riboflavin to possess prebiotic-like effects. However, there is still a lack of understanding of the exact host health benefits vs. conventional systemically available vitamin forms. The present study explores the benefit of colon-delivered vitamin B2 vs. conventional vitamin B2 in comparison to placebo in an aging population on gut microbiota and metabolic activity as well as gut health.
This description comes directly from the study's public registry record.
Veronika Bobb, Dr. · +49 30 4000 8152 · vbobb@a-r.com
Liana Vismane, Dr · +49 30 4000 8152 · lvismane@a-r.com
Always discuss trial participation with your own doctor first.
| analyze & realize GmbH | Berlin, State of Berlin, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07093463